Today: 5 February 2026
Subscribe
Browse Category

OTC:RNAZ.O News 5 February 2026

TransCode Therapeutics stock jumps on FDA filing for Phase 2a colorectal cancer trial

TransCode Therapeutics stock jumps on FDA filing for Phase 2a colorectal cancer trial

New York, Feb 5, 2026, 15:49 EST — Regular session Shares of TransCode Therapeutics Inc (RNAZ.O) jumped nearly 19% Thursday following a U.S. regulatory update related to its lead drug program. The stock traded around $10.23, swinging between $9.08 and $12.30, as volume surged to about 11.5 million shares compared to roughly 8,500 the previous day. (Investing) TransCode has filed…
5 February 2026
····

Stock Market Today

  • CIBC Boosts AutoCanada (TSE:ACQ) Price Target to C$34, Signaling 17.5% Upside
    February 5, 2026, 5:55 PM EST. CIBC raised AutoCanada's target price from C$30 to C$34, projecting 17.53% upside. The auto dealership's shares (TSE:ACQ) traded at C$28.93 on Thursday with a volume of 24,313. Other analysts show divergent views: Canaccord Genuity targets C$42 with a 'buy' rating, while ATB Capital lowered their target to C$25. The stock holds an average 'Moderate Buy' rating across research firms. AutoCanada reported quarterly revenue of C$1.20 billion but a negative net margin of 0.82%. Market capitalization stands at C$668.25 million with a P/E ratio of -72.33, reflecting recent losses. The company operates across major car brands and offers vehicle sales, parts, and financing mainly in Canada.
Go toTop